Top stories in health and medicine, March 19, 2014

From MedPage Today: Is Belphen the Next Blockbuster Diet Drug? Even though there are scant data, obesity researchers and patients have already put a name to a potential new weight-loss craze: Belphen, a combination of lorcaserin (Belviq) and phentermine. Does COPD Dull the Mind? Mild cognitive impairment was more likely in patients with chronic obstructive pulmonary disease (COPD), particularly the longer it went on. Panel Urges Higher Bar for Cancer Trials. Oncology clinical trials should be designed so that the primary endpoint of overall survival benefit is a more meaningful one, and patients should expect no less. Sepsis: Advances in Usual Care Boost Survival. Early goal-directed therapy (EGDT) did not reduce mortality among septic shock patients, when compared with bedside decision making by clinicians. Your patients are rating you online: How to respond. Manage your online reputation: A social media guide. Find out how.
Source: Kevin, M.D. - Medical Weblog - Category: Family Physicians Tags: News Cancer Endocrinology Pulmonology Source Type: blogs